Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Combinatorial Chemistry & High Throughput Screening|February 11, 2025
Identification of NR4A2 as a Potential Predictive Biomarker for AtherosclerosisLebin Yuan, Ruru Bai, Xinhao Han, et al.BMC Public Health|February 23, 2024
Associations between patterns of blood heavy metal exposure and health outcomes: insights from NHANES 2011-2016Xiangyu Wang, Xinhao Han, Shufang Guo, et al.Metabolic Engineering|July 30, 2025
De novo biosynthesis of D-panthenol in engineered E. coli with rationally designed L-homoserine decarboxylasePeng Zheng, Jie Ren, Jie Zheng, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|May 25, 2025
The impact of urinary metal exposure on cardiac injury measured by four high-sensitivity troponin assays in US adults: A nationwide cross-sectional studyYilan Li, Yue Sun, Xinhao Han, et al.ACS Applied Bio Materials|October 14, 2022
A Reversible Fluorescent Probe Based on a Redox-Switchable Excited-State Intramolecular Proton-Transfer Active Metal-Organic Framework for Detection and Imaging of Highly Reactive Oxygen Species in Live CellsShan Huang, Xinhao Han, Ying Liu, et al.Frontiers in Cell and Developmental Biology|February 7, 2022
A Novel Prognostic Tool for Glioma Based on Enhancer RNA-Regulated Immune GenesWei Tian, Kegong Chen, Guangcan Yan, et al.International Journal of Stroke : Official Journal of the International Stroke Society|June 14, 2022
The quality disparity of stroke care over time: An analysis based on the national dataset from 2011 to 2017Jingkun Li, Qihui Chen, Chao Wang, et al.Nutrients|June 19, 2024
The Association between Diet-Exercise Patterns and Cirrhosis: A Cross-Sectional Study from NHANES 2017-March 2020Jialu Liu, Xinhao Han, Lu Chen, et al.Chemosphere|March 17, 2023
Associations between the compositional patterns of blood volatile organic compounds and chronic respiratory diseases and ages at onset in NHANES 2003-2012Yuanyuan Wang, Xinhao Han, Jingkun Li, et al.International Journal of Surgery (London, England)|February 23, 2026
Adebrelimab in combination with dalpiciclib and endocrine therapy as neoadjuvant treatment for HR+/HER2- early breast cancer: an exploratory studyMin Xiao, He Ren, Xinhao Han, et al.Pageof 3